Chip-AML22 Master Protocol:  An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3-ITD/ NPM1wt Patients - a Study By the NOPHO-DB-SHIP Consortium

Gertjan J.L. Kaspers; Noa E. Wijnen; Joost B. Koedijk; Sae Ishimaru; Renske Benedictus; Ellen C. Van Opstal; Harm Van Tinteren; C. Michel Zwaan; Noha Biserna; Pamela Downs; Yvonne Duong; Yasser Mostafa Kamel; Jonas Abrahamsson; Nira Arad-Cohen; Nicole Bodmer; Luis Castillo; Daniel Cheuk; Vitor Costa; Barbara De Moerloose; Jose Maria Fernandez Navarro; Linda Fogelstrand; Bianca F. Goemans; Henrik Hasle; Olafur G. Jonsson; Zhanna Kovalova; Monica C. Munthe-Kaas; Ulrika Norén-Nyström; Sauli Palmu; Ramune Pasauliene; Kadri Saks; Anne Maria Tierens; Dominik Turkiewicz; Cornelis Jan Pronk

doi:10.1182/blood-2023-181792

Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3-ITD/ NPM1wt Patients - a Study By the NOPHO-DB-SHIP Consortium

Gertjan J.L. Kaspers, Noa E. Wijnen, Joost B. Koedijk, Sae Ishimaru, Renske Benedictus, Ellen C. Van Opstal, Harm Van Tinteren, C. Michel Zwaan, Noha Biserna, Pamela Downs, Yvonne Duong, Yasser Mostafa Kamel, Jonas Abrahamsson, Nira Arad-Cohen, Nicole Bodmer, Luis Castillo, Daniel Cheuk, Vitor Costa, Barbara De Moerloose, Jose Maria Fernandez NavarroLinda Fogelstrand, Bianca F. Goemans, Henrik Hasle, Olafur G. Jonsson, Zhanna Kovalova, Monica C. Munthe-Kaas, Ulrika Norén-Nyström, Sauli Palmu, Ramune Pasauliene, Kadri Saks, Anne Maria Tierens, Dominik Turkiewicz, Cornelis Jan Pronk

Research output: Contribution to journal › Meeting Abstract › peer-review

45 Downloads (Pure)

Original language	English
Article number	1532
Journal	Blood
Volume	142
Issue number	Suppl.1
DOIs	https://doi.org/10.1182/blood-2023-181792
Publication status	Published - 28 Nov 2023
Externally published	Yes
Event	ASH Annual Meeting - San Diego, United States Duration: 9 Dec 2023 → 12 Dec 2023 https://www.hematology.org/newsroom/annual-meeting-press/press-kit/general-annual-meeting-information-and-materials

Field of Science*

3.2 Clinical medicine

Publication Type*

3.4. Other publications in conference proceedings (including local)

Access to Document

10.1182/blood-2023-181792

Chip-AML22 Master ProtocolFinal published version, 450 KB

Cite this

Kaspers, G. J. L., Wijnen, N. E., Koedijk, J. B., Ishimaru, S., Benedictus, R., Van Opstal, E. C., Van Tinteren, H., Zwaan, C. M., Biserna, N., Downs, P., Duong, Y., Kamel, Y. M., Abrahamsson, J., Arad-Cohen, N., Bodmer, N., Castillo, L., Cheuk, D., Costa, V., De Moerloose, B., ... Pronk, C. J. (2023). Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3-ITD/ NPM1wt Patients - a Study By the NOPHO-DB-SHIP Consortium. Blood, 142(Suppl.1), Article 1532. https://doi.org/10.1182/blood-2023-181792

@article{52aa680d46694f6cb64f0b2558580445,

title = "Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3-ITD/ NPM1wt Patients - a Study By the NOPHO-DB-SHIP Consortium",

author = "Kaspers, \{Gertjan J.L.\} and Wijnen, \{Noa E.\} and Koedijk, \{Joost B.\} and Sae Ishimaru and Renske Benedictus and \{Van Opstal\}, \{Ellen C.\} and \{Van Tinteren\}, Harm and Zwaan, \{C. Michel\} and Noha Biserna and Pamela Downs and Yvonne Duong and Kamel, \{Yasser Mostafa\} and Jonas Abrahamsson and Nira Arad-Cohen and Nicole Bodmer and Luis Castillo and Daniel Cheuk and Vitor Costa and \{De Moerloose\}, Barbara and \{Fernandez Navarro\}, \{Jose Maria\} and Linda Fogelstrand and Goemans, \{Bianca F.\} and Henrik Hasle and Jonsson, \{Olafur G.\} and Zhanna Kovalova and Munthe-Kaas, \{Monica C.\} and Ulrika Nor{\'e}n-Nystr{\"o}m and Sauli Palmu and Ramune Pasauliene and Kadri Saks and Tierens, \{Anne Maria\} and Dominik Turkiewicz and Pronk, \{Cornelis Jan\}",

year = "2023",

month = nov,

day = "28",

doi = "10.1182/blood-2023-181792",

language = "English",

volume = "142",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "Suppl.1",

note = "ASH Annual Meeting, ASH ; Conference date: 09-12-2023 Through 12-12-2023",

url = "https://www.hematology.org/newsroom/annual-meeting-press/press-kit/general-annual-meeting-information-and-materials",

}

Kaspers, GJL, Wijnen, NE, Koedijk, JB, Ishimaru, S, Benedictus, R, Van Opstal, EC, Van Tinteren, H, Zwaan, CM, Biserna, N, Downs, P, Duong, Y, Kamel, YM, Abrahamsson, J, Arad-Cohen, N, Bodmer, N, Castillo, L, Cheuk, D, Costa, V, De Moerloose, B, Fernandez Navarro, JM, Fogelstrand, L, Goemans, BF, Hasle, H, Jonsson, OG, Kovalova, Z, Munthe-Kaas, MC, Norén-Nyström, U, Palmu, S, Pasauliene, R, Saks, K, Tierens, AM, Turkiewicz, D & Pronk, CJ 2023, 'Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3-ITD/ NPM1wt Patients - a Study By the NOPHO-DB-SHIP Consortium', Blood, vol. 142, no. Suppl.1, 1532. https://doi.org/10.1182/blood-2023-181792

Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3-ITD/ NPM1wt Patients - a Study By the NOPHO-DB-SHIP Consortium. / Kaspers, Gertjan J.L.; Wijnen, Noa E.; Koedijk, Joost B. et al.
In: Blood, Vol. 142, No. Suppl.1, 1532, 28.11.2023.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Chip-AML22 Master Protocol

T2 - ASH Annual Meeting

AU - Kaspers, Gertjan J.L.

AU - Wijnen, Noa E.

AU - Koedijk, Joost B.

AU - Ishimaru, Sae

AU - Benedictus, Renske

AU - Van Opstal, Ellen C.

AU - Van Tinteren, Harm

AU - Zwaan, C. Michel

AU - Biserna, Noha

AU - Downs, Pamela

AU - Duong, Yvonne

AU - Kamel, Yasser Mostafa

AU - Abrahamsson, Jonas

AU - Arad-Cohen, Nira

AU - Bodmer, Nicole

AU - Castillo, Luis

AU - Cheuk, Daniel

AU - Costa, Vitor

AU - De Moerloose, Barbara

AU - Fernandez Navarro, Jose Maria

AU - Fogelstrand, Linda

AU - Goemans, Bianca F.

AU - Hasle, Henrik

AU - Jonsson, Olafur G.

AU - Kovalova, Zhanna

AU - Munthe-Kaas, Monica C.

AU - Norén-Nyström, Ulrika

AU - Palmu, Sauli

AU - Pasauliene, Ramune

AU - Saks, Kadri

AU - Tierens, Anne Maria

AU - Turkiewicz, Dominik

AU - Pronk, Cornelis Jan

PY - 2023/11/28

Y1 - 2023/11/28

U2 - 10.1182/blood-2023-181792

DO - 10.1182/blood-2023-181792

M3 - Meeting Abstract

SN - 0006-4971

VL - 142

JO - Blood

JF - Blood

IS - Suppl.1

M1 - 1532

Y2 - 9 December 2023 through 12 December 2023

ER -

Kaspers GJL, Wijnen NE, Koedijk JB, Ishimaru S, Benedictus R, Van Opstal EC et al. Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3-ITD/ NPM1wt Patients - a Study By the NOPHO-DB-SHIP Consortium. Blood. 2023 Nov 28;142(Suppl.1): 1532. doi: 10.1182/blood-2023-181792